Newsroom Careers Contact Us

Research and Development

Global R&D Centre

Novugen's core purpose and primary source of innovation lie in our R&D efforts. Situated in the heart of Southeast Asia, our global R&D center in Malaysia, led by highly experienced scientists, is dedicated to developing challenging and technology-intensive products, including complex generics meeting USFDA standards.

Our Research & Development
R&D centre spreads across

40,000 sq. ft.
facilities

Highly qualified of over

200 scientists

Novugen Pharma is the first in ASEAN to develop products for US & EU markets

R&D Platforms

We have full capabilities to handle development services for a variety of dosage forms including:

Tablets, capsules and powders

Pellets and beads

Liquids, solutions, suspensions and emulsions

Soft Gel capsules

Parental Dosage Forms (Liquid and Lyophilized powders)

Granules for reconstitution

Drug in capsule/vial for clinical trials

Other Novel dosage forms(e.g MUPS, OCAS, DDR , etc.)

Explore Our CDO
INNOVATION

R&D Commitment

Novugen invests in cutting-edge technologies and experienced scientists for developing challenging and technology-intensive products. Our advanced labs and research center in Malaysia, specializing in oncology and other therapeutic areas, facilitate solid-state characterization for API and Finished Products, ensuring equivalence with the brand product. This allows us to successfully pass bioequivalence studies with EU and USFDA-approved Clinical Research Organizations.